These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18705749

  • 1. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor.
    Dhir A, Kulkarni SK.
    Fundam Clin Pharmacol; 2008 Aug; 22(4):387-94. PubMed ID: 18705749
    [Abstract] [Full Text] [Related]

  • 2. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
    Dhir A, Kulkarni SK.
    Neurosci Lett; 2007 Jun 15; 420(3):204-8. PubMed ID: 17532136
    [Abstract] [Full Text] [Related]

  • 3. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 4. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 5. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A, Kulkarni SK.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):177-85. PubMed ID: 17509558
    [Abstract] [Full Text] [Related]

  • 6. Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test.
    Dhir A, Kulkarni S.
    J Psychopharmacol; 2008 Aug 30; 22(6):691-6. PubMed ID: 18308813
    [Abstract] [Full Text] [Related]

  • 7. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test.
    Yamada J, Sugimoto Y, Yamada S.
    Eur J Pharmacol; 2004 Nov 19; 504(3):207-11. PubMed ID: 15541423
    [Abstract] [Full Text] [Related]

  • 8. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
    Dhir A, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):921-5. PubMed ID: 17379375
    [Abstract] [Full Text] [Related]

  • 9. Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
    Dhir A, Kulkarni SK.
    Can J Physiol Pharmacol; 2008 Oct 09; 86(10):726-35. PubMed ID: 18841177
    [Abstract] [Full Text] [Related]

  • 10. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
    Skuza G, Rogóz Z.
    J Physiol Pharmacol; 2006 Jun 09; 57(2):217-29. PubMed ID: 16845227
    [Abstract] [Full Text] [Related]

  • 11. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium.
    Cardoso CC, Lobato KR, Binfaré RW, Ferreira PK, Rosa AO, Santos AR, Rodrigues AL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):235-42. PubMed ID: 19059299
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP, Budni J, Santos AR, Rodrigues AL.
    Eur J Pharmacol; 2007 Dec 08; 576(1-3):91-8. PubMed ID: 17868670
    [Abstract] [Full Text] [Related]

  • 13. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
    Meurs A, Clinckers R, Ebinger G, Michotte Y, Smolders I.
    Eur J Neurosci; 2007 Dec 08; 26(11):3079-92. PubMed ID: 18005069
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.
    Cooper BR, Hester TJ, Maxwell RA.
    J Pharmacol Exp Ther; 1980 Oct 08; 215(1):127-34. PubMed ID: 6778989
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.
    Sugimoto Y, Tagawa N, Kobayashi Y, Mitsui-Saito K, Hotta Y, Yamada J.
    Eur J Pharmacol; 2012 Dec 05; 696(1-3):96-100. PubMed ID: 23041149
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice.
    Carrasco MC, Vicens P, Vidal J, Redolat R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov 05; 28(7):1135-41. PubMed ID: 15610926
    [Abstract] [Full Text] [Related]

  • 17. Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice.
    Kotagale NR, Mendhi SM, Aglawe MM, Umekar MJ, Taksande BG.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):180-6. PubMed ID: 23399765
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterisation of the thermogenic effect of bupropion.
    Liu YL, Connoley IP, Heal DJ, Stock MJ.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):219-25. PubMed ID: 15363998
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
    Sidhpura N, Redfern P, Rowley H, Heal D, Wonnacott S.
    Biochem Pharmacol; 2007 Oct 15; 74(8):1292-8. PubMed ID: 17678630
    [Abstract] [Full Text] [Related]

  • 20. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies.
    Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR.
    Neuropharmacology; 2005 Oct 15; 49(5):638-45. PubMed ID: 15939443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.